Chardan Capital raised their FY2025 earnings estimates for shares of Solid Biosciences in a research report issued to clients and investors on Wednesday, February 19th. Chardan Capital analyst Y.
Equities research analysts at Leerink Partnrs lowered their FY2025 earnings estimates for shares of Karyopharm Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback